Biotechnology landscape in cancer drug discovery

Monica Neagu; Radu Albulescu; Cristiana Tanase

doi:10.4155/fso.15.10

Biotechnology landscape in cancer drug discovery

Future Sci OA. 2015 Nov 1;1(3):FSO12. doi: 10.4155/fso.15.10. eCollection 2015 Nov.

Authors

Monica Neagu¹, Radu Albulescu², Cristiana Tanase³

Affiliations

¹ Immunology Laboratory, "Victor Babes" National Institute of Pathology, 99-101 Splaiul Independentei, 050096, Bucharest, Romania; Immunology Laboratory, "Victor Babes" National Institute of Pathology, 99-101 Splaiul Independentei, 050096, Bucharest, Romania.
² Biochemistry-Proteomics Laboratory, "Victor Babes" National Institute of Pathology & National Institute for Chemical Pharmaceutical R&D Bucharest; Biochemistry-Proteomics Laboratory, "Victor Babes" National Institute of Pathology & National Institute for Chemical Pharmaceutical R&D Bucharest.
³ Biochemistry-Proteomics Laboratory, "Victor Babes" National Institute of Pathology & "Titu Maiorescu" University, Faculty of Medicine; Biochemistry-Proteomics Laboratory, "Victor Babes" National Institute of Pathology & "Titu Maiorescu" University, Faculty of Medicine.

No abstract available

Keywords: cancer; drug discovery; hits and leads; immune-therapy; microRNA-based technology; next-generation sequencing; signaling pathway arrays; stem cells; technology optimization.

Publication types

Editorial